share_log

Conduit Pharmaceuticals Enters Agreement With Sarborg To Leverage AI And Cybernetics Platform To Evaluate Key Deliverables Across Multiple Areas Of Operations

Benzinga ·  Dec 12, 2024 07:36

By entering into this agreement with Sarborg, Conduit will address longstanding challenges in the pharmaceutical sector by seeking to reduce human error in critical decision-making processes including clinical development and asset identification.

Conduit will retain a perpetual, non-exclusive, royalty-free, and assignable right to use any platform or technology developed by Sarborg in association with the deliverables.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment